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The In Vitro Spheroid Melanoma  
Cell Culture Assay:  
Cues on Tumor Initiation?
Tobias Schatton1 and Markus H. Frank1,2
Cancer stem cells (CSCs) represent malignant subpopulations that initiate and 
maintain tumorigenic growth in hierarchically organized tumors via their consid-
erable capacity for self-renewal and differentiation. CSCs have been identified in 
several human malignancies, including human malignant melanoma. Perego and 
colleagues’ report in this issue indicates that CSCs capable of melanoma initia-
tion in serial human-to-mouse xenotransplantation assays may be contained both 
among spheroid melanoma cell cultures (melanospheres) and among adherent 
melanoma cultures upon in vitro expansion. These results challenge the utility of 
the melanosphere assay as a surrogate tool for CSC identification in human mela-
nomas and underline the importance of molecularly defined malignant melanoma 
initiating cells for CSC-focused diagnostic and therapeutic investigations.
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According to a consensus definition 
(Clarke, 2006), cancer stem cells (CSCs) 
are cells within hierarchically organized 
tumors that possess extensive self-renew-
al capacity and the ability to give rise to 
non-CSC progeny through differentiation. 
CSCs can be defined experimentally only 
by their ability to recapitulate the gener-
ation of a continuously growing tumor. 
Therefore, experimental identification 
and characterization of putative CSC 
subpopulations require the use of in vivo 
model systems (Clarke, 2006). The gold 
standard assay in this regard, although 
imperfect, is serial xenotransplanta-
tion of marker-defined clinical cancer 
subpopulations at limiting dilution into 
orthotopic sites of immunocompromised 
mice—typically nonobese diabetic/
severe combined immunodeficient 
(NOD/SCID) mice (Clarke, 2006) (Figure 
1). Using this approach, CSCs have been 
identified in several human malignan-
cies (reviewed in Frank, 2010), including 
human melanoma, in which malignant 
melanoma initiating cells (MMICs) are 
defined by expression of the chemore-
sistance mediator ABCB5 (Schatton, 
2008). Hierarchical tumor organiza-
tion has recently also been identified in 
syngeneic mouse models of melanoma, 
with only a fraction of murine melanoma 
cells possessing the fundamental CSC 
properties of extensive self-renewal, dif-
ferentiation, and enhanced tumorigenic 
capacity (Held, 2010).
Perego et al. (2010, this issue) report 
that molecularly heterogeneous mela-
noma cells expanded in vitro as spheroid 
cultures (melanospheres) display more 
rapid growth in vivo in human-to-mouse 
xenotransplantation experiments com-
pared with melanoma cells expanded 
as adherent cultures. At the same time, 
results of the study indicate that mela-
noma cells capable of tumor initiation in 
serial xenotransplantation experiments—
i.e., MMICs—can be present both 
among spheroid melanoma cultures and 
among adherent melanoma cultures. 
These results challenge the potential util-
ity of the melanosphere assay as a tool to 
enrich MMICs prospectively.
The sphere-formation assay was orig-
inally established as an in vitro culture 
system that enriches for mammalian 
stem cells of the central nervous sys-
tem (reviewed in Jensen, 2006). Under 
these culture conditions, neural stem 
cells preferentially grow into so-called 
neurospheres that can differentiate into 
several neural lineage subtypes, where-
as more differentiated cells die rapidly 
in response to mitogens present in the 
medium (Jensen, 2006). This in vitro 
culture system has since been adopt-
ed to assay for additional physiologic 
stem cell types, including mammary 
epithelial stem cells. Furthermore, some 
researchers have attempted to establish 
the sphere technique as a surrogate CSC 
assay, for example, for tumors of the 
brain and breast. However, the sphere 
assay suffers several disadvantages 
(Jensen, 2006): (i) it is very sensitive to 
the culturing method used (i.e., media 
composition and seeding technique), 
making it difficult to consolidate 
experimental findings from different 
laboratories; (ii) even at limiting-dilution 
plating, individual spheres often develop 
as a result of aggregation of cells rather 
than through clonal expansion; (iii) in 
some instances, more differentiated 
cells have been described as exhibit-
ing sphere-forming capability; and (iv) 
because spheroid bodies themselves 
display marked cellular heterogeneity, 
experiments using spheres should be 
interpreted as studies of mixed cell pop-
ulations, not purified stem cells. Taken 
together, these considerations have chal-
lenged the universal applicability of the 
sphere culture system as a stand-alone 
assay for the accurate enumeration of 
stem cell frequencies and for the study 
of stem cell biology in general (Jensen, 
2006). To potentially make use of the 
sphere approach as a surrogate CSC 
assay, it has been posited that its reli-
ability for the enrichment of tumor 
subpopulations of CSC phenotype and 
function must therefore be confirmed 
by stringent in vivo characterization of 
CSC activity (Clarke, 2006).
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These limitations of the sphere assay 
for CSC identification also apply to 
the study by Perego et al. (2010). For 
instance, whereas xenotransplantation 
of human melanoma cells derived from 
melanospheres to SCID mice resulted 
in significantly larger tumors com-
pared with those observed in murine 
recipients of adherent melanoma cells, 
no significant differences in tumor-for-
mation capacity were found between 
the two experimental groups (38/44 
versus 36/47 xenograft tumors, respec-
tively). In addition, both melanoma 
sphere–derived and adherent mela-
noma cell–derived xenografts could be 
passaged serially into secondary and 
tertiary recipients in vivo, demonstrat-
ing the presence of cancer cells with 
long-term self-renewal capability in 
both cell culture systems. Additionally, 
a lack of use of repurified melanoma 
cells prospectively identified by their 
ability to grow as spheroid bodies ver-
sus adherent populations in secondary 
and tertiary xenograft recipients in this 
study precludes the possibility of estab-
lishing any potential preferential asso-
ciation between CSC phenotype and 
sphere-forming ability or adherent phe-
notype. However, the results do show 
that both melanospheres and adherent 
melanoma cultures can contain tumor 
subpopulations with tumor-initiating, 
self-renewal, and proliferative capac-
ity—i.e., CSCs. This conclusion might 
help to explain the observed lack in this 
study of significant correlations between 
candidate or known CSC markers 
with sphere-forming ability. Although 
the investigators reported increased 
expression of Nanog and Oct3/4 and 
decreased expression of the melanoma-
differentiation antigen CD146 (MCAM) 
in spheroid versus adherent mela-
noma cultures, a specific relationship 
of these molecular markers to CSCs in 
human melanomas has not yet been 
established. Similarly, the capacity for 
transdifferentiation along mesenchymal 
lineages into cells with the morphology 
and antigenic properties of osteocytes, 
adipocytes, and chondrocytes (Perego 
et al., 2010) observed among mel-
anosphere-associated cells cannot be 
interpreted as being indicative of CSC 
phenotype, because tumor cell plas-
ticity is not a defining feature of CSCs 
(Clarke, 2006). Moreover, melanosphere 
expression of the differentiation anti-
gen MART-1 (Perego et al., 2010) does 
not support the view that the melano-
sphere assay enriches for CSCs, because 
MART-1 is expressed only at relatively 
low levels by MMICs (Schatton, 2010).
The finding by Perego et al. that CSCs 
in human melanomas can be contained 
both among spheroid melanoma cul-
tures and among cultured adherent 
melanoma cells is novel and extends 
previous investigations by other labo-
ratories that have sought to address a 
potential correlation of in vitro melano-
ma growth patterns (i.e., spheroid versus 
adherent growth) with the CSC pheno-
type of human melanomas (Fang, 2005; 
Keshet, 2008; Monzani, 2007). It should 
be noted that these other studies did not 
utilize serial in vivo xenotransplantation 
assays for the investigation of candidate 
CSC subpopulations and therefore fell 
short of yielding definitive insights in this 
regard. Monzani et al. (2007) found that 
tumorigenic CD133+ melanoma sub-
sets were contained exclusively among 
adherent melanoma populations, 
whereas melanoma sphere–associated 
cells did not express CD133 (Monzani, 
2007), in contrast to the current obser-
vation by Perego et al. (2010). Fang et al. 
(2005) reported increased expression of 
the B-cell marker CD20 on melanoma 
spheres compared with adherent mela-
noma cells, but the significance of this 
result remains uncertain because CD20 
expression was not detected in either 
sphere-forming or adherent melanoma 
cultures (Perego et al., 2010) or clinical 
melanoma specimens (Quintana et al., 
2008). Keshet et al. (2008) described 
increased expression of the multidrug-
resistance gene product MDR1 by mel-
anomas under melanosphere-forming 
culture conditions compared with 
Clinical Implications
•  In vitro patterns (spheroid or adherent) of melanoma growth failed to 
predict molecular or functional phenotype.
•  The results challenge the utility of the melanosphere assay as a 
surrogate tool for enriching cancer stem cells.
•  The results underline the importance of molecularly defined malignant 
melanoma initiating cells for cancer stem cell–focused diagnostic and 
therapeutic studies.
Figure 1. The gold standard assay for the study of cancer stem cells (CSCs). A CSC is a cell within 
a tumor that possesses the capacity to undergo both self-renewing cell divisions and cell divisions 
that result in more differentiated cancer cell progeny. CSCs can be defined experimentally only by 
their ability to recapitulate the generation of a continuously growing tumor. The gold standard assay 
that fulfills this criterion is serial xenotransplantation at limiting dilution of marker-defined clinical 
cancer subpopulations into an orthotopic site of immunocompromised (typically nonobese diabetic/
severe combined immunodeficient (NOD/SCID)) mice. In this assay, long-term self-renewal of CSCs 
is confirmed by serial xenotransplantation of prospectively reisolated CSC populations into secondary 
recipients. Differentiation of CSCs is typically demonstrated by their ability to generate tumor xenografts 
that reflect the cellular heterogeneity of the original patient tumor. Modifications to this assay system, 
including the exogenous addition of growth and extracellular matrix factors, may complicate biological 
readouts because they could enable non-CSCs to contribute to tumor growth.
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adherent culture conditions. In contrast, 
Perego et al. (2010) found that MDR1 
mRNA was not differentially expressed 
in melanospheres compared with adher-
ent melanoma cultures.
In aggregate, the currently avail-
able evidence does not support a sig-
nificant or preferential correlation of a 
particular in vitro melanoma growth 
pattern (i.e., spheroid or adherent 
growth) with known melanoma CSC 
molecular phenotypes or functions. 
These results challenge the utility of 
the melanosphere assay as a surrogate 
tool for enriching CSCs in human 
malignant melanoma and underline 
the importance of molecularly defined 
MMICs for CSC-focused diagnostic and 
therapeutic investigations.
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Vexed by Red-Headed Conundrums
Jonathan L. Rees1
Reduced function alleles of the melanocortin 1 receptor (MC1R) lead to red 
hair, freckling, and sun sensitivity. They are also associated with an increased 
risk of skin cancer. But what pathways link gene variants with the cancer phe-
notype? In this issue, Robinson et al. describe their use of mouse transgenics 
to demonstrate that the MC1R signaling pathway influences cancer risk via 
mechanisms in addition to pigmentation.
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“…and then off to violin-land, 
where all is sweetness...and there 
are no red-headed clients to vex us 
with their conundrums.”
—Sherlock Holmes,  
in “The Red-Headed League”
In Arthur Conan Doyle’s Sherlock 
Holmes story “The Red-Headed 
League,” the central character, Jabez 
Wilson, has fiery red hair. Ensnared by 
bank robbers, he is persuaded to leave 
his shop so that he can take up gener-
ously paid work elsewhere. Curiously, 
this well-paid work is open only to 
those with red hair, and the work itself 
appears to serve no useful function. 
The reader is left wondering what 
aspect of red hair is critical to the 
logic of the story, but the explanation 
is mundane. We learn that Wilson’s 
shop is situated next to a bank, and 
the villains want him out of the way so 
that they can tunnel into the bank next 
door. The story could therefore have 
focused on any of Wilson’s character-
istics, and red hair was used merely as 
a marker.
What of red hair and skin cancer? 
We know that most forms of skin can-
cer are more common in individu-
als with red hair and pale skin (Rees, 
2004). Does causality run from altered 
pigmentation to skin cancer, or, as in 
the story, is red hair merely a visible 
marker for some other characteristic? 
The paper by Healy’s group (Robinson 
et al., 2010, this issue) provides us 
with yet more reasons to admit that 
the link between red hair and skin 
cancer still vexes.
the evolution of human pigmentation
Human pigmentation attracts great 
interest, and not only because of its 
link with skin disease. Variation in 
human skin and hair color is one of 
the most striking polymorphic traits 
of mankind (Rees, 2004). Covariation 
of skin color, ancestry, and geography 
is obvious to most observers and has 
played a key role in human history—
for good and bad. If we were to pré-
cis human evolution over the past 
500,000 years, it would perhaps read 
as follows.
Following climate change, our 
ancestors were forced to move from 
the forest to the savannah. The need 
to hunt meant that endurance exer-
cise became essential—we may not 
have been able to outsprint other 
mammals, but humans can still out-
run a horse over marathon distances 
in a warm climate. We were therefore 
able to track and hunt prey over large 
distances. We owe much of this abil-
ity to the way our skin is designed. 
Humans are covered by 3 to 5 million 
eccrine glands, and we are astonish-
ingly capable of losing body heat gen-
erated by physical activity. However, 
sweating was more efficient if evapo-
ration could take place unimpeded 
by hair; thus humans became—to use 
the cliché—naked. This in turn led 
